Linked Data API

Show Search Form

Search Results

1604953
registered interest false more like this
date less than 2023-03-16more like thismore than 2023-03-16
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Obesity: Health Services more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps he is taking to help tackle obesity in adults. remove filter
tabling member constituency York Central more like this
tabling member printed
Rachael Maskell more like this
uin 167183 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2023-03-20more like thismore than 2023-03-20
answer text <p>In addition to the answer I gave the hon. Member on 27 February 2023 to Question 151337, the weight loss drug Semaglutide (Wegovy) will be available on the National Health Service within three months of its launch in the United Kingdom with eligibility in line with National Institute for Health and Care Excellence recommendations to ensure clinically and cost effective use.</p> more like this
answering member constituency Harborough more like this
answering member printed Neil O'Brien more like this
question first answered
less than 2023-03-20T16:25:00.913Zmore like thismore than 2023-03-20T16:25:00.913Z
answering member
4679
label Biography information for Neil O'Brien more like this
tabling member
4471
label Biography information for Rachael Maskell more like this